Unknown

Dataset Information

0

Identification of Human Papillomavirus Infection in Cancer Tissue by Targeted Next-generation Sequencing.


ABSTRACT: Human papillomaviruses (HPV) are oncogenic DNA viruses implicated in squamous cell carcinomas of several anatomic sites, as well as endocervical adenocarcinomas. Identification of HPV is an actionable finding in some carcinomas, potentially influencing tumor classification, prognosis, and management. We incorporated capture probes for oncogenic HPV strains 16 and 18 into a broader next-generation sequencing (NGS) panel designed to identify actionable mutations in solid malignancies. A total of 21 head and neck, genitourinary, and gynecologic squamous cell carcinomas and endocervical adenocarcinomas were sequenced as part of the UNCSeq project. Using p16 immunohistochemical results as the gold standard, we set a cutoff for proportion of aligned HPV reads that maximized performance of our NGS assay (92% sensitive, 100% specific for HPV). These results suggest that sequencing of oncogenic pathogens can be incorporated into targeted NGS panels, extending the clinical utility of genomic assays.

SUBMITTER: Montgomery ND 

PROVIDER: S-EPMC4791202 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of Human Papillomavirus Infection in Cancer Tissue by Targeted Next-generation Sequencing.

Montgomery Nathan D ND   Parker Joel S JS   Eberhard David A DA   Patel Nirali M NM   Weck Karen E KE   Sharpless Norman E NE   Hu Zhiyuan Z   Hayes David Neil DN   Gulley Margaret L ML  

Applied immunohistochemistry & molecular morphology : AIMM 20160801 7


Human papillomaviruses (HPV) are oncogenic DNA viruses implicated in squamous cell carcinomas of several anatomic sites, as well as endocervical adenocarcinomas. Identification of HPV is an actionable finding in some carcinomas, potentially influencing tumor classification, prognosis, and management. We incorporated capture probes for oncogenic HPV strains 16 and 18 into a broader next-generation sequencing (NGS) panel designed to identify actionable mutations in solid malignancies. A total of 2  ...[more]

Similar Datasets

| S-EPMC3660257 | biostudies-literature
| S-EPMC7507370 | biostudies-literature
| S-EPMC5744626 | biostudies-literature
| S-EPMC4627247 | biostudies-literature
| 2206884 | ecrin-mdr-crc
2017-04-03 | PXD003804 | Pride
| S-EPMC5466385 | biostudies-literature
| S-EPMC9280450 | biostudies-literature
| S-EPMC4940024 | biostudies-literature
| S-EPMC4858692 | biostudies-literature